|
| All patients | CCC | KUH | p value |
| Number of patients | 26 | 21 | 5 |
|
| Age (years) | 63 (41 - 78) | 63 (41 - 78) | 66 (53 - 81) | 0.379 |
| Sex |
|
|
| 0.376 |
| Male | 15 (57.7) | 13 (61.9) | 2 (40.0) | |
| Female | 11 (42.3) | 8 (38.1) | 3 (60.0) | |
| ECOG PS |
|
|
| 0.121 |
| 0 | 21 (80.8) | 16 (76.2) | 5 (100.0) | |
| 1 | 5 (19.2) | 5 (23.8) | 0 | |
| Previous nephrectomy |
|
|
| 0.509 |
| Yes | 25 (96.2) | 20 (95.2) | 5 (100.0) | |
| No | 1 (3.8) | 1 (4.8) | 0 | |
| Histology of primary tumor |
|
|
| 0.536 |
| Clear cell RCC | 23 (88.5) | 19 (90.5) | 4 (80.0) | |
| Non-clear cell RCC | 3 (11.5) | 2 (9.5) | 1 (20.0) | |
| MSKCC risk group |
|
|
| 0.947 |
| Favorable | 6 (23.1) | 5 (23.8) | 1 (20.0) | |
| Intermediate | 16 (61.5) | 13 (61.9) | 3 (60.0) | |
| Poor | 4 (15.4) | 3 (14.3) | 1 (20.0) | |
| Site of metastasis |
|
|
|
|
| Lung | 18 (69.2) | 15 (71.4) | 3 (60.0) | 0.549 |
| Lymph node | 12 (46.2) | 9 (42.9) | 3 (60.0) | 0.490 |
| Bone | 7 (26.9) | 7 (33.3) | 0 | 0.059 |
| Liver | 2 (7.7) | 2 (9.5) | 0 | 0.345 |